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Abstract Hypoglycemic effect of cyanobacteria has
evaluated in the normal and streptozotocin-induced dia-
betic male albino rats as a mammalian model. Normal and
streptozotocin-diabetic rats were orally administered
cyanobacteria for 60 consecutive days, and their blood
levels of glucose, insulin, C-peptide, lipid peroxidation,
body weight and enzyme changes were determined using
standard methods. Cyanobacteria administration reduced
blood glucose level, and increased plasma insulin, C-pep-
tide levels and restored the body weight. Cyanobacteria
administration significantly reduced lipid peroxidation in
the diabetic rats. Hexokinase enzyme activity was
increased, whereas glucose-6-phosphatase enzyme activity
decreased in streptozotocin-diabetic rats compared to their
respective controls. Cyanobacteria administration caused
significant renormalization of serum hepatic enzymes in
streptozotocin-induced diabetic rats. In conclusion,
cyanobacteria have a protective effect on anti-oxidant and
anti-diabetic in streptozotocin-induced diabetic rats.
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Introduction
Diabetes mellitus is a metabolic disorder in which there are
high blood glucose levels over a prolonged time. Type 1
diabetes mellitus is due to the body’s failure to produce
enough amount of insulin. Type 2 diabetes mellitus starts
with insulin resistance, a condition in which cells unable to
respond to insulin properly (Muthuraman et al. 2014a,
b). The number of diabetics is tremendously increasing in
developing countries due to lifestyle (Sridhar et al. 2002).
The careful control of blood glucose is a vital part of the
management of diabetic complications (Muthuraman and
Srikumar 2009). There are several anti-diabetic drugs
available to control blood glucose level; however, these
drugs produce side effects. There are five major kinds of
anti-diabetic drugs such as sulfonylureas, meglitinides,
biguanides, thiazolidinediones and alpha-glucosidase inhi-
bitors available in the market. However, these drugs pro-
duce several side effects such as hypoglycemia, skin
allergy, skin rash, gastrointestinal upset, fluid retention,
edema, weight gain, lactic acidosis, nausea, diarrhea, liver
function impairment and flatulence. Therefore, a search of
the novel anti-diabetic drug without any side effect is
mandatory in the clinical research.
The intravenous injection of streptozotocin in male
albino Wistar rats makes pancreas swell and causes
degeneration of Langerhans islet beta cells of the pancreas
and induces experimental diabetes mellitus within 72 h.
Streptozotocin induces one type of diabetes which is sim-
ilar to diabetes mellitus with non-ketosis hyperglycemia.
Induction of diabetes with Streptozotocin decreases
nicotinamide adenine dinucleotide in pancreatic islet beta
cells and causes histopathological effects in beta cells of
the pancreas which probably intermediates induction of
diabetes.
Several natural products have isolated from a broad
range of taxa and tested for biomedical potential. These
active components from plant origin have provided several
crucial molecules for drug designing. The search of prod-
ucts from natural sources has revolutionized the programs
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of drug discovery. Several plant-derived molecules have
shown a promising potential effect in therapeutics. The use
of plant medicines in the treatment of several diseases such
as central nervous system disorders is a traditional practice.
The cyanobacteria (spirulina platens) have been recog-
nized for their wide abundance. Cyanobacteria are con-
sidered as good candidates for applications in agriculture,
food industry and pharmaceuticals. Antibacterial, antiviral,
antifungal, algaecides and cytotoxic activities of
cyanobacteria have been reported (Senthilkumar and
Ahmed John 2008). Cyanobacteria contain secondary
metabolites, bioactive peptides, macrolides and glycosides
(Matthew et al. 2010). Cyanobacteria occur naturally in
tropical and subtropical lakes with high pH and high con-
centrations; therefore, their concentrated nutritional profile
makes it ideal for those preferring a whole-food supple-
ment to artificial nutrient sources. A search for novel
compounds is essential to conquering diabetes mellitus
without side effect. Also, cyanobacterial strains have been
well characterized, with some anti-oxidant and anti-in-
flammatory potential (Nagasathya and Thajuddin 2003;
Rajavel et al. 2009). Our previous study evaluated the
effect of cyanobacteria on plasma insulin and increased by
regeneration of pancreatic beta cells in alloxan induced
diabetic rats following administration (Muthuraman et al.
2009). The present study was therefore undertaken to
investigate the chronic effect of cyanobacteria in strepto-
zotocin-induced diabetes in male albino rats.
Materials and methods
Male Wistar strain albino rats weighing 160–180 g have
used for the investigation. The animals have housed under
controlled temperature and hygiene conditions in propy-
lene cages. Commercial rat chow with free access to
drinking water ad libitum was provided for the rats.
Experiments were carried out in accordance with interna-
tionally accepted ethical guidelines for the care of labora-
tory animals. A freshly prepared solution of streptozotocin
(40 mg/kg) in 0.1 M citrate buffer was injected intraperi-
toneally (i.p.). Following 3 and 4 days of streptozotocin
administration, blood was collected from the rats by eye
bleeding method. Rats exhibiting a blood glucose level
more than 300 mg/dl were believed to be diabetic and
selected for the experiment. A total of 24 rats were used for
the study. Rats were divided into four groups of six animals
each: group 1: normal control rats, group 2: normal rats
given cyanobacteria (20 mg/kg body weight), group 3:
diabetic control rats, group 4: diabetic rats given
cyanobacteria (20 mg/kg body weight). Cyanobacteria
were administered orally using oral gavage for 60 con-
secutive days. Normal saline acted as a vehicle. At the end
of 60 days, blood was collected from the animals by eye
bleeding method for the further experiments.
Preparation of the cyanobacteria extract
Cyanobacteria have cultivated by mass culture. Biomass
was collected by centrifugation, washed twice with dis-
tilled water, and freeze-dried. The freeze-dried biomass
was mixed with distilled water to give a 10 % (w/v) sus-
pension and heated at 95 C for 30 min. The extract was
purified by centrifugation at 10,000 rev/min for 15 min and
stored lyophilized until use (Muthuraman et al. 2009).
Biochemical profile
Blood glucose in each sample was estimated by the stan-
dard method (Haidari et al. 2012). Plasma insulin was
measured by radioimmunoassay method (Life Technolo-
gies, Korea) (Ezuruike and Prieto 2014). The C-peptide
level was assayed by the chemiluminescence immunoassay
method (Sigma-Aldrich, Korea) (Jones and Hattersley
2013). The body weight of rats was also determined.
Enzymes
Glycolytic enzymes such as hexokinase (Muthuraman and
Srikumar 2010) and glucose-6-phosphatase (Kirana and
Srinivasan 2010) have measured by kit methods (Sigma-
Aldrich, Korea). Serum hepatic marker enzymes such as
alanine transaminase (ALT), aspartate transaminase (AST)
and gamma-glutamyl transpeptidase (GGT) were measured
by kit methods (Life Technologies, Korea) (Muthuviveg-
anandavel et al. 2008).
Lipid peroxidation
Lipid peroxidation (LPO) was determined by the kit
method (Cell Biolabs, Inc, Korea). This was based on the
spectrophotometric method of Muthuraman et al. (2014a,
b). MDA was measured by determining the thiobarbituric
acid reactive species. The absorbance of the resultant
product has measured at 534 nm (Agilent Technologies,
Cary 100 UV–Vis spectrophotometer).
Statistical analysis
All values have expressed as mean ± SEM. Statistical
analysis has carried with the use of SPSS 11 software. The
statistical significance of differences between the means
has assessed by student ‘‘t’’ test. A difference at p\ 0.05
has considered statistically significant.
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Results
Cyanobacteria administration caused significant changes in
the levels of glucose, plasma insulin, C-peptide, lipid
peroxidation, body weights and serum hepatic marker
enzymes in diabetic rats compared to control rats. Six rats
were used for each analysis (n = 6). Glucose levels ele-
vated and plasma insulin levels decreased significantly in
streptozotocin-induced diabetic rats. Body weight also
seemed to be increased compared to a normal rat. How-
ever, the chronic administration of cyanobacteria restored
these parameters to normal levels.
Blood glucose, insulin, and C-peptide
Blood glucose content was significantly reduced to
151.1 ± 4.1 mg/dl in streptozotocin-induced diabetic rats
following cyanobacteria administration, whereas it was
115.3 ± 2.7 mg/dl. The blood glucose level of the diabetic
rats selected for the study was above 300 mg/dl (Fig. 1).
The plasma insulin level was found to be lower 5 ± 0.08
microunit/ml in the streptozotocin-induced diabetic rats
when compared to normal rats (13.5 ± 0.3 microunit/ml).
Cyanobacteria administration significantly increased the
plasma insulin level 7.9 ± 0.1 microunit/ml in diabetic
rats, and to a lesser degree in normal rats (Fig. 2). A C-
peptide level also was found to be lower 0.68 ± 0.02 ng/
ml in the streptozotocin-induced diabetic rats when
compared to normal rats. Cyanobacteria administration
significantly increased the C-peptide level 1.1 ± 0.04 ng/
ml in the male albino diabetic rats (Fig. 3).
Body weight changes
Cyanobacteria reversed weight loss in diabetic rats and
yielded a lesser effect in the normal rats. At the end
treatment time, body weights of rats were 195 ± 3.4,
188 ± 5, 140 ± 3 and 173 ± 4.1 g b.wt in group I, group
II, group III and group IV, respectively. The body weight
changes have calculated before and after cyanobacteria
administration.
Glycolytic enzyme activity
Cyanobacteria administration increased hexokinase activ-
ity 140 ± 4 units/mg of protein in streptozotocin-induced
diabetic rats, whereas lesser (155 ± 5.3 units/mg of pro-
tein) extent in normal rats (Fig. 4). Cyanobacteria admin-
istration reduced glucose-6-phosphatase activity
0.182 ± 0.004 units/mg of protein in diabetic rats, whereas
minor reductions in the normal rat (Fig. 5).
Lipid peroxidation
The level of lipid peroxidation was found to be increased
(45 ± 2 nmol/mg of protein) in streptozotocin-induced
Fig. 1 Effect of cyanobacteria
on serum glucose level in
normal and streptozotocin-
induced diabetic male albino
rats following 60 consecutive
days of dose (20 mg/k.bwt)
administration. All the values
were expressed as mean ± SD,
*p\ 0.05, n = 6
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diabetic rats. Cyanobacteria administration significantly
reduced lipid peroxidation level 27 ± 1.9 nmol/mg of
protein in diabetic rats, whereas it was an insignificant
reduction in normal rats (Fig. 6).
Serum hepatic marker enzymes
The activity of serum hepatic marker enzymes such as
ALT, AST, and GGT enzyme activity is elevated
Fig. 2 Effect of cyanobacteria
on plasma insulin level in
normal and streptozotocin-
induced diabetic male albino
rats following 60 consecutive
days of dose (20 mg/k.bwt)
administration. All the values
were expressed as mean ± SD,
*p\ 0.05, n = 6
Fig. 3 Effect of cyanobacteria
on the C-peptide level in normal
and streptozotocin-induced
diabetic male albino rats
following 60 consecutive days
of dose (20 mg/k.bwt)
administration. All the values
were expressed as mean ± SD,
*p\ 0.05, n = 6
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42.0 ± 1.8, 92.3 ± 4.2 and 31.6 ± 1.5 U/L, respec-
tively, in the streptozotocin-induced diabetic rats.
Cyanobacteria administration significantly reduced these
enzyme levels, whereas minor reductions in normal rats
(Table 1).
Discussion
We evaluated the chronic effect of cyanobacteria on dia-
betic-biochemical markers such as blood glucose content,
plasma insulin, C-peptide, lipid peroxidation, weight
Fig. 4 Effect of cyanobacteria
on serum hexokinase enzyme
activity in normal and
streptozotocin-induced diabetic
male albino rats following 60
consecutive days of dose
(20 mg/k.bwt) administration.
All the values were expressed as
mean ± SD, *p\ 0.05, n = 6
Fig. 5 Effect of cyanobacteria
on serum glucose-6-phosphatase
activity in normal and
streptozotocin-induced diabetic
male albino rats following 60
consecutive days of dose
(20 mg/k.bwt) administration.
All the values were expressed as
mean ± SD, *p\ 0.05, n = 6
3 Biotech (2016) 6:94 Page 5 of 7 94
123
changes and glycolytic, serum hepatic marker enzyme
changes in streptozotocin-induced diabetic male albino
rats. Also, cyanobacteria were administered to the normal
rats to evaluate the effect in normal condition. Streptozo-
tocin has been widely used for diabetes induction in animal
studies (Graham et al. 2011). Streptozotocin induced dia-
betes as indicated by the symptoms such as glycosuria,
hyperglycemia, polyphagia, polydipsia and body weight
loss (Deeds et al. 2011).
Cyanobacteria administration significantly renormalized
altered biochemical markers in streptozotocin-induced
diabetic rats. Glucose, plasma insulin, C-peptide, lipid
peroxidation and enzyme levels have evaluated in the
control and treated groups. Cyanobacteria administration
significantly reduced the glucose level in the streptozo-
tocin-induced diabetic rats, whereas no significant reduc-
tion in normal rats, which agrees with our previous findings
(Muthuraman et al. 2009). Cyanobacteria administration
increased plasma insulin and C-peptide levels in the dia-
betic rats to the near normal levels, while no significant
changes have observed in the normal rats. Increased plasma
insulin and C-peptide levels were indicative of the fact that
cyanobacteria may enhance the secretion of insulin from
the pancreas.
Also, cyanobacteria administration results in gaining
weight in diabetic rats, and this may be due to its anti-
hyperglycemic potential. Increased glucose-6-phosphatase
could utilize for the conversion of carbohydrates to fat.
Increased hexokinase enzyme activity indicates the higher
rate glycolysis (Anitha and Chandra 2006). Hexokinase
and glucose six phosphatase enzyme activities have not
significantly changed in the normal rats following
cyanobacteria administration. Reduced lipid peroxidation
in diabetic rats indicates the anti-oxidant potential of
Fig. 6 Effect of cyanobacteria
on lipid peroxidation in normal
and streptozotocin-induced
diabetic male albino rats
following 60 consecutive days
of dose (20 mg/k.bwt)
administration. All the values
were expressed as mean ± SD,
*p\ 0.05, n = 6
Table 1 Effect of cyanobacteria on serum hepatic marker enzyme activity in normal and streptozotocin-induced diabetic male albino rats
following 60 consecutive days of dose (20 mg/k.bwt) administration
Serum hepatic marker enzymes Control Control with cyanobacteria Diabetic control Diabetic with cyanobacteria
ALT (U/L) 21.9 ± 0.5 20.1 ± 1.2 42.0 ± 1.8 26.0 ± 1.3***
AST (U/L) 56.2 ± 2.1 54.0 ± 3.0 92.3 ± 4.2 66.5 ± 2.7*
GGT (U/L) 17.5 ± 0.9 15.7 ± 0.8 31.6 ± 1.5 20.1 ± 0.6*
All the values are expressed mean ± SEM
* p\ 0.05; *** p\ 0.001, n = 6
94 Page 6 of 7 3 Biotech (2016) 6:94
123
cyanobacteria. ALT, AST, and GGT are indicators of
hepatic damage (Whitehead et al. 1999). These enzymes
increased in streptozotocin-induced diabetic rats due to
hepatic damage. Cyanobacteria administration reduced the
activities of these enzymes to the near normal levels.
Therefore, the anti-hypoglycemic action of cyanobacteria
mediated through potentiation of pancreatic secretion of
insulin from the intact beta cells of the islets.
Conclusion
Our experimental results indicated that the cyanobacteria
administration renormalized the glucose, insulin, C-pep-
tide, lipid peroxidation and glycolytic enzymes. Also,
administration of cyanobacteria leads to regaining body
weight in diabetic rats. Cyanobacteria administration
reversed the hepatic damage by renormalizing of serum
hepatic marker enzymes. Taking all these together,
cyanobacteria show anti-hypoglycemic action through
potentiation of pancreatic secretion of insulin from the
intact beta cells of the islets.
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